VICTOR HORADAM, M.D.
Medical Oncology Physician · MESQUITE, TX
Individual Active NPI 1881636991
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 181 | 65,268 | $2,226,812 | $577,448 | $459,209 |
| 2023 | 201 | 51,619 | $1,856,314 | $411,692 | $327,288 |
| 2022 | 107 | 13,621 | $593,153 | $144,960 | $116,265 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J1756 | Injection, iron sucrose, 1 mg | 11,600 | $0 | $0 |
| J1453 | Injection, fosaprepitant, 1 mg | 3,150 | $0 | $0 |
| J9271 | Injection, pembrolizumab, 1 mg | 2,700 | $56 | $44 |
| A9585 | Injection, gadobutrol, 0.1 ml | 2,050 | $0 | $0 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,835 | $0 | $0 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 520 | $0 | $0 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 300 | $1 | $1 |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | 71 | $124 | $99 |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 65 | $60 | $46 |
| 96372 | Injection of drug or substance under skin or into muscle | 60 | $14 | $10 |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 53 | $28 | $22 |
| 96375 | Injection of additional new drug or substance into vein | 51 | $14 | $12 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | E6425 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Texas
- NPI 1457367112
- NPI 1720010507
- NPI 1346287992
- NPI 1700828548
- NPI 1346331063
- NPI 1497319636
- NPI 1346323888
- NPI 1447414776
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.